NEXVET BIOPHARMA PUB LTD CO's ticker is NVET and the CUSIP is G6503X109. A total of 17 filers reported holding NEXVET BIOPHARMA PUB LTD CO in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $123,000 | – | 16,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,332 | $2,578,000 | 0.78% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,503,696 | $9,113,000 | 0.12% |
| CQS Cayman LP | 30,400 | $111,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 875,000 | $3,185,000 | 0.01% |
| COWEN INC. | 27,485 | $100,000 | 0.01% |
| NEXT Financial Group, Inc | 1,100 | $4,000 | 0.00% |
| JENNISON ASSOCIATES LLC | 262,056 | $954,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,325,555 | $4,825,000 | 0.00% |
| Virtu KCG Holdings LLC | 23,785 | $87,000 | 0.00% |
| NORGES BANK | 35,313 | $129,000 | 0.00% |